Dr. Percy Kwabena Adonteng-Boateng, MD

Dr. Adonteng-Boateng practices at Adena Dialysis in Pompano Beach, Florida.

Dr. Adonteng-Boateng's NPI, 1972959419, was assigned on May 13, 2016. Dr. Adonteng-Boateng holds Ohio license 35.135005.

Dr. Adonteng-Boateng's primary practice is Adena Dialysis, at 3890 Park Central N Blvd, Pompano Beach, FL 33064 in Broward County. The practice phone is (740) 773-3733.

Dr. Adonteng-Boateng's primary practice is Adena Dialysis in Pompano Beach, Florida. Dr. Adonteng-Boateng is also affiliated with Adena Regional Medical Center. The medical group on file is Adena Health System. Dmand AI also links Dr. Adonteng-Boateng to 4 more hospitals, 3 dialysis centers, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adonteng-Boateng practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Adonteng-Boateng's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Adonteng-Boateng is licensed in Ohio.

CMS data shows 684 Medicare services from Dr. Adonteng-Boateng across 13 procedure codes in 2024, for 252 Medicare patients. Medicare paid $65,590 for them.

CMS counts 252 Medicare patients who saw Dr. Adonteng-Boateng in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 4.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adonteng-Boateng's median patient age at 73, with 56% women.

In 2024, Dr. Adonteng-Boateng wrote 1,298 Medicare Part D claims for 267 patients. 85% of them were for generic drugs. CMS names the drug for 1,152 of them, across 22 drugs with 11 or more claims each, at $201,878 in total drug cost. In 2023, CMS named 94 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Adonteng-Boateng for performance year 2024, reported as part of a group. Dr. Adonteng-Boateng accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Adonteng-Boateng, published from 2017 to 2018. 2018 was the busiest year, with 2. The most frequent topics are Hypertension, Pulmonary and Lung. Dr. Adonteng-Boateng's most frequent co-authors are Wassim H. Fares, MD, MS, Isabel Sofia Bazan, MD and Benjamin M. Cherry, MD.

CMS Open Payments shows 86 general payments to Dr. Adonteng-Boateng from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $460.